General
Preferred name
LOMITAPIDE
Synonyms
BMS-201038 mesylate ()
AEGR-733 mesylate ()
AEGR-733 ()
BMS-201038 ()
LOMITAPIDE MESYLATE ()
Lomitapide (mesylate) ()
AEGR-733, BMS-201038 ()
AEGR-733 Mesylate,BMS-2138 Mesylate ()
Lomitapida ()
Lojuxta ()
BMS-201038-01 ()
Aegr-733 mesilate ()
AEGR-733 MESYLATE ()
BMS-201038-04 ()
Lomitapide mesilate ()
Juxtapid ()
Lomitapide-d8 ()
P&D ID
PD009190
CAS
182431-12-5
202914-84-9
2459377-96-7
Tags
available
drug
Approved by
FDA
First approval
2012
Drug indication
Hypercholesterolemia
Familial hypercholesterolemia
Cardiovascular disease
Drug Status
approved
investigational
Max Phase
4.0
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION
Lomitapide is a lipid-lowering agent for the treatment of familial hypercholesterolemia.
(GtoPdb)
DESCRIPTION
Lomitapide (AEGR-733; BMS-201038) is a potent inhibitor of microsomal triglyceride-transfer protein (MTP) with an IC50 of 8 nM in vitro.
PRICE
172
DESCRIPTION
Lomitapide (AEGR-733; BMS-201038) mesylate is a highly effective MTP protein inhibitor with an in vitro IC50 value of 8nM.
PRICE
116
DESCRIPTION
Lomitapide is a microsomal triglyceride transfer protein inhibitor used to lower cholesterol associated with homozygous familial hypercholesterolemia, reducing risk of cardiovascular events such as myocardial infarction and stroke.
(Enamine Bioactive Compounds)
DESCRIPTION
Lomitapide (AEGR-733) is a small molecule inhibitor of microsomal triglyceride transfer protein (MTP), an enzyme located in the lumen of the endoplasmic reticulum responsible for absorbing dietary lipids and transferring triglycerides onto apolipoprotein B (apo-B) in the assembly of very-low-density lipoprotein.
(TargetMol Bioactive Compound Library)
DESCRIPTION
Lomitapide Mesylate is a potent microsomal triglyceride transfer protein (MTP) inhibitor, used in the treatment of familial hypercholesterolemia.
(BOC Sciences Bioactive Compounds)
DESCRIPTION
Lomitapide Mesylate (BMS-201038 mesylate) is a methanesulfonic acid form of lomitapide, a small molecule inhibitor of microsomal triglyceride transfer protein.
(TargetMol Bioactive Compound Library)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
24
AdooQ Bioactive Compound Library
Axon Medchem Screening Library
BOC Sciences Bioactive Compounds
ChEMBL Approved Drugs
ChEMBL Drugs
Drug Repurposing Hub
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
DrugMAP
DrugMAP Approved Drugs
Enamine Bioactive Compounds
EU-OPENSCREEN Bioactive Compound Library
Guide to Pharmacology
LSP-MoA library (Laboratory of Systems Pharmacology)
Mcule NIBR MoA Box Subset
NCATS Inxight Approved Drugs
Novartis Chemogenetic Library (NIBR MoA Box)
ReFrame library
Selleckchem Bioactive Compound Library
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
79
Molecular Weight
693.28
Hydrogen Bond Acceptors
3
Hydrogen Bond Donors
2
Rotatable Bonds
10
Ring Count
6
Aromatic Ring Count
4
cLogP
8.38
TPSA
61.44
Fraction CSP3
0.33
Chiral centers
0.0
Largest ring
6.0
QED
0.13
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Target
MTP
MTTP
MTP inhibitor
Microsomal Triglyceride Transfer Protein (MTP)
LDLR
MTOR
Member status
member
MOA
Microsomal Triglyceride Transfer Protein (MTTP) Inhibitors
microsomal trigylceride transfer protein inhibitor
Indication
hypercholesterolemia
Pathway
Metabolism
Metabolic Enzyme/Protease
Apoptosis
Autophagy
PI3K/Akt/mTOR
Source data

